Women's Health Market Grew to $350 Billion Opportunity

A new study reveals that many women feel underserved by existing longevity products and services.

Updated on Sept. 28, 2026 in Women’s Health

Bold flat-color editorial illustration of a glass hourglass on a plinth, symbolizing clinical longevity and healthspan market opportunities.
A Boston Consulting Group study identifies a $350 billion market opportunity in women's health, highlighting a critical gap in targeted longevity and perimenopause care. AI Illustration. Upload story photo >

Live Poll

Do you believe the health and longevity industry currently prioritizes women's specific wellness needs?

A Boston Consulting Group study conducted for the St Moritz Longevity Forum has identified a $350 billion market opportunity in women's health. The findings highlight that current longevity interventions often fail to meet the specific needs of women in perimenopause and menopause.

Why it matters

As demand for long-term health solutions grows, the industry faces a gap in providing evidence-backed care for women. This shift signals a potential pivot toward more targeted, clinically-supported wellness options for those seeking to extend their healthspan.

A study by the Boston Consulting Group examined the current landscape of the longevity market. While women in perimenopause and menopause are active users, the data indicates high dissatisfaction with existing offerings compared to the total identified market potential of $350 billion.

The players

Boston Consulting Group

A global management consulting firm that provides research and strategic advice on industry trends.

St Moritz Longevity Forum

An international platform that hosts discussions on the future of extending human healthspan.

The details

The longevity sector currently relies on a wide array of generic wellness interventions designed to delay ill health. The study indicates that these existing solutions lack the clinical evidence required by women navigating the biological changes of perimenopause and menopause. Future developments will need to focus on rigorous, data-driven approaches to healthspan extension to capture this underserved segment.

Timeline

  1. September 2026: The study results were released.

Health Landscape

This research marks a significant push to re-evaluate the longevity industry's approach to female physiology. It highlights a departure from one-size-fits-all wellness models toward solutions grounded in evidence-based medicine.

If you are managing perimenopause or menopause, this research validates the need to seek out care backed by clinical evidence rather than generic wellness trends. Discuss your specific symptoms and health goals with your doctor to ensure your longevity plan is based on proven outcomes.

The takeaway

The longevity market is currently failing to meet the specific physiological needs of women entering perimenopause and menopause. When evaluating wellness interventions, always prioritize products or programs that have undergone clinical testing over those supported primarily by marketing claims.

Further reading

For more on the current research landscape, explore Women’s Health.

Source note: This article includes information reported by Healthcare-digital.

Live Poll

Do you believe the health and longevity industry currently prioritizes women's specific wellness needs?